Patent · US Active

Group A Streptococcus vaccine

US10301362B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

GRIFFITH UNIVERSITY · AU

Inventors

Manisha Pandey · Forsayth, AU
Michael Batzloff · Calle de la Era, AU
Michael Good · Forsayth, AU

Key dates

Filing date	Apr 15, 2015
Grant date	May 28, 2019
Priority date	—
Expiry date	Apr 15, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method and composition for eliciting an immune response to group A streptococcal bacteria in a mammal is provided, which includes administering to the mammal an M protein fragment, variant or derivative thereof and a SpyCEP protein or peptide fragment, or an antibody to the SpyCEP protein or fragment to facilitate restoring or enhancing neutrophil activity. Also provided is an immunodominant peptide fragment of SpyCEP.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.